Researchers are excited about Retatrutide , a innovative dual treatment showing promising results in early trials for body loss . It acts by targeting two pathways : GLP-1 and GIP, which , when stimulated, help control appetite and improve metabolism . Early reports indicate substantial body loss and likely improvements for patients struggling obes